Evidence map›Paper›PMID 41303513›Full record

ArticleInternational journal of molecular sciences2025

Dysfunction of the Autophagy System and MDM2-p53 Axis Leads to the Accumulation of Amyloidogenic Proteins in Angelman Syndrome Models.

Jacqueline Fátima Martins de Almeida, Martina Contestabile, Ilaria Tonazzini, Chiara De Cesari, Laura Baroncelli, Claudia Martini, Simona Daniele

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jacqueline Fátima Martins de AlmeidaDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Martina ContestabileDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Ilaria TonazziniIstituto Nanoscienze, Consiglio Nazionale delle Ricerche (CNR)@NESTe, Piazza San Silvestro 12, 56127 Pisa, Italy.ORCID 0000-0002-7323-2174
Chiara De CesariIstituto Nanoscienze, Consiglio Nazionale delle Ricerche (CNR)@NESTe, Piazza San Silvestro 12, 56127 Pisa, Italy.ORCID 0009-0004-2305-966X
Laura BaroncelliIstituto Neuroscienze, CNR, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.ORCID 0000-0001-6739-2860
Claudia MartiniDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-9379-3027
Simona DanieleDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7391-3087

Funding

MIUR PRIN2022 2022ZH5M72
6 · The paper itself

Abstract

Angelman Syndrome (AS) is a neurodevelopmental disorder caused by the deficiency of the UBE3A gene that for a E3 ligase protein part of the ubiquitin-proteasome system (UPS). Autophagy and UPS systems remove abnormal proteins, but any dysfunction in these processes can affect neuronal development and wellbeing. Herein, the involvement of the UPS/autophagy system in the regulation of intracellular signaling pathways related to toxic protein accumulation was investigated in cellular/mice AS models, silenced for UB3A (UB3A

Indexed as

Amyloid beta-Protein PrecursorAngelman SyndromeAutophagyProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53AnimalsCell Line, TumorDisease Models, AnimalFemaleHumansMaleMiceMice, Inbred C57BLProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesAmyloid beta-Protein PrecursorProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mdm2TOR Serine-Threonine KinasesTumor Suppressor Protein p53UBE3A protein, humanUbe3a protein, mouseUbiquitin-Protein Ligasesamyloid proteinsAngelman syndromeautophagyprotein accumulationubiquitin–proteasome system

Identifiers

PMID41303513
PMCPMC12652799

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.